Success Metrics

Active Trials
1(25%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Enrolling by invitation2
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A

Trials by Status

enrolling_by_invitation250%
active_not_recruiting125%
not_yet_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruiting

VLA1553-403 Pregnancy Surveillance Study

NCT07414524
active_not_recruiting

Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

NCT07163845
enrolling_by_invitation

Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

NCT07254702
enrolling_by_invitation

Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil

NCT07347002

Clinical Trials (4)

Showing 4 of 4 trials
NCT07414524

VLA1553-403 Pregnancy Surveillance Study

Not Yet Recruiting
NCT07163845

Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

Active Not Recruiting
NCT07254702

Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

Enrolling By Invitation
NCT07347002

Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil

Enrolling By Invitation

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4